Shenzhen Kangtai Biological Products

Shenzhen Kangtai Biological Products (also known as SZKT) is a leading biopharmaceutical company based in Shenzhen, China. The company specializes in the research, development, and manufacturing of vaccines and other biological products.

History

Shenzhen Kangtai Biological Products was established in 1992. Since its inception, the company has been committed to the development and production of vaccines to prevent various infectious diseases. It has played a significant role in the public health sector in China and has contributed to the global fight against infectious diseases.

Products

Shenzhen Kangtai Biological Products has a diverse product portfolio, which includes vaccines for Hepatitis B, Influenza, Pneumococcal disease, and Meningococcal disease. The company's Hepatitis B vaccine is one of the most widely used vaccines in China.

Research and Development

The company has a robust Research and Development (R&D) department, which is dedicated to the development of new vaccines and biological products. The R&D team works closely with various research institutions and universities to conduct cutting-edge research in the field of biopharmaceuticals.

Partnerships

Shenzhen Kangtai Biological Products has formed strategic partnerships with several international pharmaceutical companies. In 2020, the company entered into a collaboration with AstraZeneca to manufacture and supply the COVID-19 vaccine in mainland China.

See Also

• Biopharmaceutical
• Vaccine
• AstraZeneca
• COVID-19 vaccine

This biopharmaceutical related article is a stub. You can help WikiMD by expanding it.